Perrigo approval
This article was originally published in The Tan Sheet
Executive Summary
Generics firm receives ANDA approval Sept. 23 for 100 mg/5 mL ibuprofen oral suspension, equivalent to McNeil's Children's Motrin. Perrigo and Alpharma recently settled FTC antitrust charges over a 1998 marketing agreement under which Perrigo marketed a Children's Motrin equivalent during Alpharma's exclusivity period (1"The Tan Sheet" Aug. 16, 2004, p. 3)...
You may also be interested in...
Rx Or OTC Statins May Be Springboard For Perrigo Generics Unit
Perrigo is looking into developing its own line of private label statin drugs
FTC Settlement May Portend Antitrust Scrutiny Of ANDA First-Filer Deals
The Federal Trade Commission's settlement with Perrigo and Alpharma suggests that deals struck between competing first-to-file generic drug manufacturers may trigger future antitrust scrutiny
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.